Alternatives to Intellia Therapeutics

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing gene editing therapies to lower cholesterol.

Scalable, one-time curative in-vivo gene editing therapies.

Developing gene editing therapies for rare genetic diseases.

Biotechnology company developing cell and gene therapies for serious diseases.

VI Therapeutics is developing novel therapies for rare genetic diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

A global oncology company developing and commercializing innovative cancer treatments.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotech company developing next-generation gene writing tools for advanced therapies.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing treatments for rare inherited diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotechnology company developing novel immunotherapies for cancer.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing transformative treatments for severe genetic diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Global marketplace connecting researchers with human biospecimens for life science research.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

AI-powered spatial biology platform for precision medicine and drug development.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

AI-powered platform for antibody discovery and development to create new medicines.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Synthego provides engineered CRISPR gene editing tools and services for life sciences research.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biopharmaceutical company focused on rare genetic diseases of obesity.

Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases.